Ms Sonja M Shelley, SLP in Silver City, NM - Speech-Language Pathologist

Ms Sonja M Shelley, SLP is a Speech-language Pathologist based in Silver City, New Mexico. Ms Sonja M Shelley is licensed to practice in New Mexico (license number 1718) and her current practice location is 2810 N Swan St, Silver City, New Mexico. She can be reached at her office (for appointments etc.) via phone at (575) 956-2000.

NPI number for Ms Sonja M Shelley is 1861791741 and her current mailing address is 2810 N Swan St, Silver City, New Mexico. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1861791741.

Contact Information

	Ms Sonja M Shelley, SLP
	2810 N Swan St, Silver City, NM 88061-5853
	(575) 956-2000
	(575) 956-2055

Healthcare Provider's Profile

Full Name	Ms Sonja M Shelley
Gender	Female
Speciality	Speech-language Pathologist
Location	2810 N Swan St, Silver City, New Mexico
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1861791741
Provider Enumeration Date: 03/18/2011
Last Update Date: 03/18/2011

Medical Identifiers

Medical identifiers for Ms Sonja M Shelley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861791741	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	1718 (New Mexico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Sonja M Shelley is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Sonja M Shelley, SLP 2810 N Swan St, Silver City, NM 88061-5853 Ph: (575) 956-2000	Ms Sonja M Shelley, SLP 2810 N Swan St, Silver City, NM 88061-5853 Ph: (575) 956-2000

News Archive

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Inovio Pharmaceuticals, Inc. , a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved high vaccine-induced response rates and strong magnitude of immune responses in its Phase I clinical study of PENNVAX-B, a DNA vaccine for the prevention of HIV infection.

Nashville hospitals cut costs to keep up revenues, despite fewer patients

"Over the past year and a half, keeping costs in check has helped the large hospital chains based in the Nashville area to increase quarterly earnings, even when seeing fewer patients come through their doors," The Tennessean reports. "The recent second quarter was no different. Cost controls fueled an 18 percent increase in net income at Franklin-based Community Health Systems, despite a decline in the number of patients. HCA Inc. saw fewer inpatient visits, and higher interest expense kept its pre-tax profits flat.

AEterna Zentaris terminates its agreement on cetrorelix with sanofi-aventis U.S.

AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.

Finding could lead to new treatments for osteoporosis

Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth. The finding could lead to new treatments for osteoporosis and other diseases that occur when the body doesn't make enough bone.

Gamma Medica, Volpara Solutions partner to improve breast cancer screening

Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman's breast density and individual risk factors.

Speech-Language Pathologist in Silver City, NM

Megan Mcnutt, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 Copper Ridge Dr, Silver City, NM 88061 Phone: 505-554-8491
Jason Saenz, M.A., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4156 N Gold St, Silver City, NM 88061 Phone: 575-519-0210
Barbara H. Gabioud, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2810 N Swan St, Silver City, NM 88061 Phone: 505-956-2000 Fax: 505-956-2055
Sue Ann Childers, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2810 N Swan St, Silver City, NM 88061 Phone: 505-956-2000 Fax: 505-956-2055
Nora G. Trammell-lowe, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2810 N Swan St, Silver City, NM 88061 Phone: 505-956-2000
Christina R Delgado, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2810 N Swan St, Silver City, NM 88061 Phone: 505-956-2090
Krisandra K. Wamsley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2810 N Swan St, Silver City, NM 88061 Phone: 575-956-2040

Ms Sonja M Shelley, SLP - Speech-Language Pathologist in Silver City, NM